Search company, investor...
Sequenta company logo



Acquired | Acquired

Total Raised


About Sequenta

Sequenta is a biotechnology company dedicated to improving patient care in diseases mediated by immune cells through the discovery and development of novel clinical diagnostics. Sequenta markets a laboratory developed test for use in the diagnosis and monitoring of minimal residual disease in blood cancers.

Headquarters Location

400 E Jamie Court Suite 301

South San Francisco, California, 94080,

United States


Missing: Sequenta's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Sequenta's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Sequenta

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Sequenta is included in 4 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

2,623 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health IT

7,901 items

Sequenta Patents

Sequenta has filed 34 patents.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Immune system, Clusters of differentiation, Transcription factors, Immunology


Application Date


Grant Date



Related Topics

Molecular biology, Immune system, Clusters of differentiation, Transcription factors, Immunology



Latest Sequenta News

After Sequenta Acquisition, Adaptive Biotechnologies Raises $195M Round

May 6, 2015

VentureWire , May 06, 2015, (c) 2015 Dow Jones & Company, Inc. Adaptive Biotechnologies Corp ., which recently acquired venture-backed diagnostics company Sequenta Inc ., has raised $195 million in a Series F financing that brings its total equity funding to $400 million. Adaptive uses next-generation sequencing to profile receptors on the surface of T cells and B cells of the immune system. These receptors scan the "bar codes" of pathogen invaders. When these receptors find a match, they launch an immune cascade that leads to the destruction of these pathogens and to the immune system's memory of them.... Document DJFVW00120150506eb56qb6id To continue reading this story login at the top right or try the product Document DJFVW00120150506eb56qb6id Exclusive news and deep analysis of what’s really happening with venture capital-backed companies, their investors,and their management teams.

Sequenta Frequently Asked Questions (FAQ)

  • Where is Sequenta's headquarters?

    Sequenta's headquarters is located at 400 E Jamie Court, South San Francisco.

  • What is Sequenta's latest funding round?

    Sequenta's latest funding round is Acquired.

  • How much did Sequenta raise?

    Sequenta raised a total of $43.46M.

  • Who are the investors of Sequenta?

    Investors of Sequenta include Adaptive Biotechnologies, Celgene, Mohr Davidow Ventures, Medicxi Ventures, Foresite Capital and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.